GlassScriptPhysician profile
Kwasi A Debra
NPI 1972512408
$745.05
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $285 · 2021: $48.89 · 2022: $67.29 · 2023: $23.30 · 2024: $43.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $66.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $66.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $211.10 | 2019-2020 | |
| Abbvie INC. | $155.29 | 2019-2023 | Botox |
| Medtronic Vascular, INC. | $102.81 | 2019 | |
| Tactile Systems Technology INC | $84.68 | 2020-2021 | |
| Revance Therapeutics, INC. | $43.31 | 2024 | Daxxify |
| Myovant Sciences INC. | $38.95 | 2022 | |
| Renovia INC | $32.84 | 2020 | |
| Lumenis, INC | $24.73 | 2021 | |
| Allergan, INC. | $20.32 | 2019 | |
| Apyx Medical Corporation | $18.10 | 2019 | |
| Novo Nordisk INC | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kwasi Debra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.